Ovidrel: all 24 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- hCG Treatment for Rehabilitation From a TBINot yet recruitingNCT07557615Early Phase 1
- FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural CyclesRecruitingNCT07425990Not applicable
- hCG Priming in Women With Diminished Ovarian ReserveRecruitingNCT07108621Phase 3
- Impact of the Presence of the Corpus Luteum on Pregnancies Obtained Through Frozen Embryo Transfer(FET)RecruitingNCT06896617Phase 4
- Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOSRecruitingNCT03905603Early Phase 1
- Study of NTx®-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke PatientsTerminatedNCT00938314Phase 2Results posted
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.TerminatedNCT06511791Phase 1
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian StimulationTerminatedNCT06466486Phase 1
- Clinical Research Study to Learn About the Effect and Safety of Different Doses of FE 999302 When Given as a Single Dose for Final Development of the Eggs After Ovarian StimulationWithdrawnNCT05571111Phase 2
- hCG Priming in Women With Low Ovarian ReserveCompletedNCT04643925Phase 4
- A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.CompletedNCT03564509Phase 2
- Endometrial Preparation in Frozen Embryo Transfer CyclesStatus unknownNCT03540979Not applicable
- Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 CarriersCompletedNCT03495609Phase 4
- Triggering of Follicular MaturationCompletedNCT02916173Phase 3
- Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective StudyStatus unknownNCT02825290Phase 4
- Effectiveness and Safety Study of Fixed Versus Flexible of Gonadotropin-releasing Hormone Antagonist ProtocolStatus unknownNCT02635607Not applicable
- Comparing the Efficacy of Urinary and Recombinant Human Chorionic Gonadotropin (hCG) on Oocyte MaturityCompletedNCT01507376Phase 3
- Optimal rhCG(Ovidrel®) Dose in Poor Responder During IVF and ICSI CyclesStatus unknownNCT01406600Not applicable
- Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor RespondersStatus unknownNCT01205009Not applicable
- Endometrial Advancement After Rec or u-HCG TriggeringCompletedNCT00953628Phase 4
- REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke PatientsWithdrawnNCT00715364Phase 2
- REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke PatientsTerminatedNCT00663416Phase 2
- Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High RespondersStatus unknownNCT00415766Phase 4
- hCG Supplementation in Frozen-Thawed Embryo Transfer CycleCompletedNCT00398229Phase 2